Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalos

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Schizophrenia Research|December 4, 2016
Psychological well-being and mental health recovery in the NIMH RAISE early treatment programJulia Browne, David L Penn, Piper S Meyer-Kalos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2020
The Association of <i>MUC16</i> Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous MelanomaXuefeng Wang, Xiaoqing Yu, Michael Krauthammer, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Health Technology Intervention After Hospitalization for Schizophrenia: Service Utilization and User SatisfactionAmit Baumel, Christoph U Correll, Marta Hauser, et al.
Psychological Medicine|May 31, 2022
Relapse prevention through health technology program reduces hospitalization in schizophreniaPhilipp Homan, Nina R Schooler, Mary F Brunette, et al.
Schizophrenia Research|December 16, 2018
Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospitalEric D Achtyes, Dror Ben-Zeev, Zhehui Luo, et al.
Archives of Medical Science : AMS|July 14, 2022
Hypertensive urgencies during the first wave of the COVID-19 pandemic in a tertiary hospital setting: a U-shaped alarming curveIoannis Leontsinis, Vasilios Papademetriou, Christina Chrysohoou, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2010
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.
Schizophrenia Research|July 13, 2017
Demographic and clinical correlates of substance use disorders in first episode psychosisMary F Brunette, Kim T Mueser, Steven Babbin, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Schizophrenia Research|December 4, 2016
Psychological well-being and mental health recovery in the NIMH RAISE early treatment programJulia Browne, David L Penn, Piper S Meyer-Kalos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2020
The Association of <i>MUC16</i> Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous MelanomaXuefeng Wang, Xiaoqing Yu, Michael Krauthammer, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Health Technology Intervention After Hospitalization for Schizophrenia: Service Utilization and User SatisfactionAmit Baumel, Christoph U Correll, Marta Hauser, et al.
Psychological Medicine|May 31, 2022
Relapse prevention through health technology program reduces hospitalization in schizophreniaPhilipp Homan, Nina R Schooler, Mary F Brunette, et al.
Schizophrenia Research|December 16, 2018
Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospitalEric D Achtyes, Dror Ben-Zeev, Zhehui Luo, et al.
Archives of Medical Science : AMS|July 14, 2022
Hypertensive urgencies during the first wave of the COVID-19 pandemic in a tertiary hospital setting: a U-shaped alarming curveIoannis Leontsinis, Vasilios Papademetriou, Christina Chrysohoou, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2010
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.
Schizophrenia Research|July 13, 2017
Demographic and clinical correlates of substance use disorders in first episode psychosisMary F Brunette, Kim T Mueser, Steven Babbin, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Pageof 24